EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Comparative Evaluation of the Vasorelaxant Effects of F-1 and F-3 on Aorta and Pulmonary artery: Integrated In Vitro, In Vivo and In Silico Approaches

Bakiyeva Muazzam Sharifjanovna, Gusakova Svetlana Valeryevna, Sherzod Niyatqobulovich Zhurakulov, Rustamova Shohista Omonjonovna, Mavlanova Sadbarxon Abdukarimovna, Sharipova Nazifa Nasimovna, Xodjayeva Naimaxon Umirzaqovna, Xafizova Klaraxon Abdumannabovna, Xayitbayev Azamat Madaminovich, Dadamirzayeva Kamola Abduhalimovna, Yunusova Rayhona Melsbek qizi, Xolmirzyeva Nazira Azimjon qizi

Trends in Sciences · 25.08.2026 · 24 (1) · 14004

DOI: 10.48048/tis.2027.14004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 25.08.2026. Verfasst von Bakiyeva Muazzam Sharifjanovna und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the vasomodulatory and antihypertensive effects of compounds 1-Phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-1) and 1-(3′-hydroxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (F-3) using an integrated approach combining in silico molecular docking, in vitro functional assays, and in vivo experimental models. Molecular docking analysis revealed that both compounds exhibit high binding affinity toward calcium-regulating targets, particularly the L-type calcium channel (Cav1.2), with binding energies of −8.2 kcal/mol (F1) and −8.1 kcal/mol (F3), indicating stable ligand–protein interactions and potential modulation of calcium influx. In vitro experiments demonstrated that both compounds significantly inhibited phenylephrine-induced vascular smooth muscle contraction in a concentration-dependent manner. F1 exhibited higher potency (IC₅₀ = 3.1×10⁻⁷ M) compared to F3 (IC₅₀ = 4.29×10⁻⁶ M), showing a more consistent and gradual inhibitory profile. Additionally, both compounds enhanced the vasorelaxant effect of verapamil and partially attenuated the inhibitory action of phentolamine, suggesting involvement in both calcium channel modulation and adrenergic signaling pathways. The reduction of their effects in the presence of L-NAME indicates partial dependence on nitric oxide-mediated mechanisms. In vivo studies in adrenaline-induced hypertensive rats demonstrated that F1 and F3 significantly reduced systolic and diastolic blood pressure in a dose- and time-dependent manner at doses of 10, 25, and 50 mg/kg. F1 showed a more pronounced antihypertensive effect, effectively restoring blood pressure toward physiological levels. Overall, the findings indicate that F1 is a more potent vasorelaxant and antihypertensive agent than F3. The observed effects are mediated through a multi-target mechanism involving inhibition of calcium influx, modulation of adrenergic signaling, and partial involvement of nitric oxide pathways. These results highlight F1 as a promising candidate for the development of novel therapeutic agents for the treatment of hypertension and vascular dysfunction. HIGHLIGHTS F1 and F3 demonstrated significant vasorelaxant activity in vitro and ex vivo models Both compounds inhibited KCl- and phenylephrine-induced vascular contractions in a concentration-dependent manner F1 exhibited higher potency and efficacy compared to F3 across all experimental conditions Vasorelaxant effects were partially independent of nitric oxide, as confirmed using L-NAME In vivo studies showed marked reductions in systolic and diastolic blood pressure F1 produced stronger and more sustained antihypertensive effects than F3 Molecular docking revealed high binding affinity to L-type (Cav1.2) and R-type calcium channels Interactions were mainly mediated by hydrophobic and π-related mechanisms Calcium channel modulation is a key mechanism underlying the observed pharmacological effects F1 is a promising candidate for further development as a cardiovascular therapeutic agent GRAPHICAL ABSTRACT

Zitieren

APA

Sharifjanovna, B. M., Valeryevna, G. S., Zhurakulov, S. N., Omonjonovna, R. S., Abdukarimovna, M. S., Nasimovna, S. N., Umirzaqovna, X. N., Abdumannabovna, X. K., Madaminovich, X. A., Abduhalimovna, D. K., qizi, Y. R. M., & qizi, X. N. A. (2026). A Comparative Evaluation of the Vasorelaxant Effects of F-1 and F-3 on Aorta and Pulmonary artery: Integrated In Vitro, In Vivo and In Silico Approaches. Trends in Sciences, 24(1), 14004. https://doi.org/10.48048/tis.2027.14004

Vancouver

Sharifjanovna BM, Valeryevna GS, Zhurakulov SN, Omonjonovna RS, Abdukarimovna MS, Nasimovna SN, et al. A Comparative Evaluation of the Vasorelaxant Effects of F-1 and F-3 on Aorta and Pulmonary artery: Integrated In Vitro, In Vivo and In Silico Approaches. Trends in Sciences. 2026;24(1):14004. doi:10.48048/tis.2027.14004

BibTeX
@article{Sharifjanovna2026,
  author = {Sharifjanovna, Bakiyeva Muazzam and Valeryevna, Gusakova Svetlana and Zhurakulov, Sherzod Niyatqobulovich and Omonjonovna, Rustamova Shohista and Abdukarimovna, Mavlanova Sadbarxon and Nasimovna, Sharipova Nazifa and Umirzaqovna, Xodjayeva Naimaxon and Abdumannabovna, Xafizova Klaraxon and Madaminovich, Xayitbayev Azamat and Abduhalimovna, Dadamirzayeva Kamola and qizi, Yunusova Rayhona Melsbek and qizi, Xolmirzyeva Nazira Azimjon},
  title = {A Comparative Evaluation of the Vasorelaxant Effects of F-1 and F-3 on Aorta and Pulmonary artery: Integrated In Vitro, In Vivo and In Silico Approaches},
  journal = {Trends in Sciences},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {14004},
  doi = {10.48048/tis.2027.14004}
}
Kostenlos starten →